916326-10-8Relevant articles and documents
Synthesis of ethyl nicotinate-5-boronic acid pinacol ester and its application toward Suzuki coupling
Leblanc, Yves,Cerat, Pascal
, p. 2775 - 2781 (2008)
A method for the synthesis and isolation of pure ethyl nicotinate-5-boronic acid pinacol ester has been described. This boronate ester was used to prepare C2-C5 heteroarylnicotinates in good yields. Copyright Taylor & Francis Group, LLC.
PHTHALAZINES AS POTASSIUM ION CHANNEL INHIBITORS
-
Page/Page column 58, (2014/09/29)
A compound of formula (I), wherein A, R1, R3, and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
PYRROLOPYRIDAZINES AS POTASSIUM ION CHANNEL INHIBITORS
-
Page/Page column 49, (2014/09/29)
A compound of formula (I) wherein A, R1, R3, and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
Regioselective conversion of arenes to N-aryl-1,2,3-triazoles Using C-H Borylation
Srinivasan, Rajavel,Coyne, Anthony G.,Abell, Chris
supporting information, p. 11680 - 11684 (2014/10/15)
A one-pot protocol for the synthesis of N-aryl 1,2,3-triazoles from arenes by an iridium-catalyzed C-H borylation/copper catalyzed azidation/click sequence is described. 1mol % of Cu(OTf)2 was found to efficiently catalyze both the azidation and the click reaction. The applicability of this method is demonstrated by the late-stage chemoselective installation of 1,2,3-triazole moiety into unactivated molecules of pharmaceutical importance.
PYRROLOTRIAZINES AS POTASSIUM ION CHANNEL INHIBITORS
-
Page/Page column, (2014/09/29)
A compound of formula (I) wherein A, R1, R3, and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment of arrhythmia, maintaining normal sinus rhythm, IKur-associated disorders, and other disorders mediated by ion channel function.
PI3 KINASE/mTOR DUAL INHIBITOR
-
Page/Page column 5, (2012/07/28)
The present invention provides an imidazo[4,5-c]quinolin-2-one compound, or a pharmaceutically acceptable salt thereof, that inhibits both PI3K and mTOR and, therefore, is useful in the treatment of cancer.